Kvíz spojený s průvodcem · Střední úroveň
AI and Liquid Biopsy for Cancer Quiz
Tests cell-free DNA methylation, cancer-signal origin, positive and negative result limits, NHS-Galleri trial outcomes, and FDA advisory status.
Otázka 1 z 8
Jaký molekulární vzorec analyzuje Galleriho test popsaný FDA?
Náhled každé otázky8 otázky
Odpovědi a vysvětlení se zobrazují, jak budete v kvízu.
- Jaký molekulární vzorec analyzuje Galleriho test popsaný FDA?
- Mutations in every cancer cell from a biopsy
- Cancer-associated methylation patterns in cell-free DNA
- Antibodies specific to all tumor types
- Proteins measured only inside tumor tissue
- Co představuje výsledek Cancer Signal Origin?
- A pathology-confirmed tumor location
- A guarantee that the predicted organ contains cancer
- A prediction of the likely anatomic source of a detected signal
- A map of all cells in the body
- Co by mělo následovat po výsledku detekce signálu rakoviny?
- A diagnostic workup recommended by qualified healthcare professionals
- Immediate cancer treatment without more testing
- A decision to stop other screenings
- A repeat blood test in place of evaluation
- Jak by měl někdo interpretovat Žádný signál rakoviny nebyl zjištěn?
- It proves no cancer is present
- It confirms symptoms are harmless
- It removes the need for future screening
- It does not rule out cancer; continue guideline-recommended screening
- Co se stalo s primárním cílovým parametrem studie NHS-Galleri?
- The study proved fewer cancer deaths
- The reduction in combined stage III and IV cancers was not achieved
- The trial did not include a control group
- The test replaced all standard screening
- What does a favorable FDA advisory committee vote mean?
- It automatically authorizes commercial use
- It guarantees Medicare coverage
- It is a non-binding recommendation, not final FDA authorization
- It replaces a premarket application
- Why can a test with high specificity still miss many cancers?
- Sensitivity and specificity describe different error types
- Specificity is the number of cancers found
- A negative signal confirms all tumor types are absent
- High specificity guarantees high sensitivity
- Which result would establish that screening saves lives?
- A high cancer-origin prediction score alone
- A single positive test result
- A reduction in time to sequence a sample
- Evidence of a mortality benefit in appropriately designed follow-up